相关实验视频
Updated: May 21, 2025

02:26
Intracranial Pharmacotherapy and Pain Assays in Rodents
Published on: April 9, 2019
5.1K
胺可以通过细胞类型和输入特定的适应在核中拯救anhedonia accumbens
Federica Lucantonio1, Jacob Roeglin2, Shuwen Li2
1Department of Psychiatry, Washington University in St. Louis School of Medicine, St. Louis, MO, USA; Taylor Family Institute for Innovative Psychiatric Research, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.
Neuron
|March 20, 2025
概括
胺可以迅速缓解无情感,这是抑郁症的核心症状. 这项研究揭示了胺恢复了核突中的突触强度,这对其抗抑郁作用至关重要.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 精神病学是一个精神病学.
背景情况:
- 胺显示出快速的抗抑郁作用,特别是在治疗耐药性抑郁症.
- 抑郁症的关键症状 - - 无症 - - 通过胺酸有效治疗,但它的神经机制尚不清楚.
- 腹核 (NAc) 参与奖励处理和抑郁症.
研究的目的:
- 为了研究核 (NAc) 在胺胺对无情感的抗抑郁作用中的作用.
- 为了阐明基他胺在慢性压力小鼠模型中的有效性背后的突触变化.
- 为了确定参与胺的治疗作用的特定神经元电路.
主要方法:
- 利用慢性压力小鼠模型来诱导无情.
- 服用了胺,并评估了行为恢复.
- 采用细胞特异性药理学,光遗传学和化学遗传学来研究NAc中的突触可塑性.
- 将神经元输入映射到NAc中的表达D1多巴胺受体的中神经元 (D1-MSN) 中.
主要成果:
- 胺治疗在小鼠中挽救了压力诱导的无情感.
- 单次胺暴露恢复了NAc D1-MSN上的激发性突触的强度.
- 对于持续的抗抑郁作用,D1-MSNs的突触恢复是必要的.
- 人工增强D1-MSN的突触强度模仿了胺的行为益处.
- 来自中部前额皮层和腹部海马体的单突触输入被确定为前突触起源.
结论:
- 核对于胺胺对无情感的抗抑郁作用至关重要.
- 在NAc D1-MSN上恢复激发性突触强度是胺作用的关键机制.
- 特定的前额叶皮和海马体对NAc的预测介导着胺的治疗影响.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
145
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
145
Parenteral Anesthetics: Overview
91
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
91
Adrenergic Agonists: Indirect-Acting Agents
1.4K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.4K
Drugs Affecting Neurotransmitter Release or Uptake
914
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
914

